EFFICACY AND FREQUENCY OF INTRAVITREAL AFLIBERCEPT VERSUS BEVACIZUMAB FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION
Retina (Philadelphia, Pa.) | 3 Aug 2017
A Lotfy, KAM Solaiman, A Abdelrahman and A Samir
To compare the safety, efficacy, and frequency of intravitreal injection of aflibercept and bevacizumab for treatment of macular edema secondary to central retinal vein occlusion.
* Data courtesy of Altmetric.com